Medical Data Vision Co., Ltd.

TSE:3902 Stok Raporu

Piyasa değeri: JP¥21.3b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Medical Data Vision Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Medical Data Vision is forecast to grow earnings and revenue by 22.5% and 10.9% per annum respectively. EPS is expected to grow by 22.5% per annum. Return on equity is forecast to be 18.6% in 3 years.

Anahtar bilgiler

22.5%

Kazanç büyüme oranı

22.5%

EPS büyüme oranı

Healthcare Services kazanç büyümesi15.0%
Gelir büyüme oranı10.9%
Gelecekteki özkaynak getirisi18.6%
Analist kapsamı

Low

Son güncelleme29 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Sep 19
Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Aug 10
Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Jun 25
Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Jun 13
Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Kazanç ve Gelir Büyüme Tahminleri

TSE:3902 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (JPY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20268,7101,0079161,0413
12/31/20257,8607877317253
12/31/20247,0776205215673
6/30/20246,197448103250N/A
3/31/20246,248689N/AN/AN/A
12/31/20236,4199791,5861,616N/A
9/30/20236,264753N/AN/AN/A
6/30/20236,2507931,5171,577N/A
3/31/20236,152832N/AN/AN/A
12/31/20226,104870857910N/A
9/30/20226,0471,164N/AN/AN/A
6/30/20225,8931,125967989N/A
3/31/20225,7541,091N/AN/AN/A
12/31/20215,6721,0871,0581,082N/A
9/30/20215,378872N/AN/AN/A
6/30/20215,1688651,2231,253N/A
3/31/20214,966858N/AN/AN/A
12/31/20204,579700937964N/A
9/30/20204,422770N/AN/AN/A
6/30/20204,286700722738N/A
3/31/20204,199637N/AN/AN/A
12/31/20194,0265541,1211,202N/A
9/30/20193,931522N/AN/AN/A
6/30/20193,891329490607N/A
3/31/20193,743188N/AN/AN/A
12/31/20183,577692120N/A
9/30/20183,519137N/AN/AN/A
6/30/20183,36418260231N/A
3/31/20183,283257N/AN/AN/A
12/31/20173,225354N/A486N/A
9/30/20173,009178N/AN/AN/A
6/30/20172,929272N/A635N/A
12/31/20162,632178N/A196N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 3902's forecast earnings growth (22.5% per year) is above the savings rate (0.3%).

Kazançlar ve Piyasa: 3902's earnings (22.5% per year) are forecast to grow faster than the JP market (8.7% per year).

Yüksek Büyüme Kazançları: 3902's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 3902's revenue (10.9% per year) is forecast to grow faster than the JP market (4.2% per year).

Yüksek Büyüme Geliri: 3902's revenue (10.9% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 3902's Return on Equity is forecast to be low in 3 years time (18.6%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y